Bilcare Limited (NSE:BI)
India · Delayed Price · Currency is INR 62.02
+0.72 (1.17%)
At close: Jul 20, 2026
Bilcare Market Cap
Bilcare has a market cap or net worth of 1.46 billion as of July 20, 2026. Its market cap has decreased by -11.77% in one year.
Market Cap
1.46B
Enterprise Value
6.39B
Revenue
7.34B
Ranking
n/a
PE Ratio
84.98
Stock Price
62.02
ChartMarket Cap Chart
Since December 17, 2003, Bilcare's market cap has increased from 1.11B to 1.46B, an increase of 31.82%. That is a compound annual growth rate of 1.23%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 20, 2026 | 1.46B | -22.08% |
| Dec 31, 2025 | 1.88B | 21.50% |
| Dec 31, 2024 | 1.54B | -17.03% |
| Dec 29, 2023 | 1.86B | 107.97% |
| Dec 30, 2022 | 894.72M | -54.38% |
| Dec 31, 2021 | 1.96B | 91.27% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Accretion Pharmaceuticals | 1.84B |
| Sanjivani Paranteral | 1.79B |
| Oxygenta Pharmaceutical | 1.79B |
| Parnax Lab | 1.69B |
| Bio Medica Laboratories | 1.65B |
| Speciality Medicines | 1.63B |
| Bilcare | 1.46B |
| Bal Pharma | 1.39B |